Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	galactoside binding	LGALS9C LGALS9B SLC2A3	2.30e-05	9	132	3	GO:0016936
GeneOntologyMolecularFunction	carbohydrate binding	LGALS9C CRYBG2 LGALS9B PKD1L2 SLC2A3 CEMIP2 NOMO1 NOMO2 MRC2 NOMO3	4.13e-05	310	132	10	GO:0030246
GeneOntologyMolecularFunction	transmembrane transporter activity	ABCC3 ABCA2 TPCN2 SLC43A1 PKD1L1 SLC34A2 SLC13A3 PKD1L2 ABCA9 SLC2A3 SLC52A3 CACNA2D4 SLC16A1 SLC18A1 SV2B SV2A CYB561D1 TIMM17A SLC25A19 KCNT1	9.52e-05	1180	132	20	GO:0022857
GeneOntologyMolecularFunction	transporter activity	ABCC3 ABCA2 TPCN2 SLC43A1 PKD1L1 SLC34A2 SLC13A3 PKD1L2 ABCA9 SLC2A3 SLC52A3 CACNA2D4 SLC16A1 SLC18A1 SV2B SV2A CYB561D1 LRP2 TIMM17A SLC25A19 KCNT1	1.09e-04	1289	132	21	GO:0005215
GeneOntologyMolecularFunction	collagen binding	COL5A3 ADGRG6 MRC2 MMP9 USH2A	2.00e-04	81	132	5	GO:0005518
GeneOntologyBiologicalProcess	transport across blood-brain barrier	ABCC3 ABCA2 SLC13A3 SLC2A3 SLC16A1 LRP2 LRP3	1.50e-06	87	133	7	GO:0150104
GeneOntologyBiologicalProcess	vascular transport	ABCC3 ABCA2 SLC13A3 SLC2A3 SLC16A1 LRP2 LRP3	1.63e-06	88	133	7	GO:0010232
GeneOntologyBiologicalProcess	multi-pass transmembrane protein insertion into ER membrane	NOMO1 NOMO2 NOMO3	2.14e-05	9	133	3	GO:0160063
GeneOntologyCellularComponent	multi-pass translocon complex	NOMO1 NOMO2 NOMO3	2.10e-05	9	134	3	GO:0160064
GeneOntologyCellularComponent	ER membrane insertion complex	NOMO1 NOMO2 NOMO3	8.90e-05	14	134	3	GO:0072379
MousePheno	abnormal placental transport	ERN1 RB1 SLC2A3 SLC52A3	2.43e-06	14	101	4	MP:0004265
MousePheno	increased T-helper cell number	LGALS9C LGALS9B POLB UNC93B1 MMP9	5.08e-05	56	101	5	MP:0013763
MousePheno	increased CD4-positive, alpha-beta T cell number	LGALS9C HBS1L LGALS9B POLB TG LMBR1L UNC93B1 MMP9 DNAJC3	6.10e-05	241	101	9	MP:0008074
Domain	-	LGALS9C LGALS9B COL5A3 ADGRG6 CELSR1 FAT2 LRBA USH2A	3.25e-07	95	130	8	2.60.120.200
Domain	DUF2012	NOMO1 NOMO2 NOMO3	1.31e-06	4	130	3	PF09430
Domain	DUF2012	NOMO1 NOMO2 NOMO3	1.31e-06	4	130	3	IPR019008
Domain	Carb-bd-like_fold	NOMO1 NOMO2 NOMO3	1.80e-05	8	130	3	IPR013784
Domain	EGF_LAM_2	STAB2 CELSR1 NTN5 USH2A	5.34e-05	30	130	4	PS50027
Domain	EGF_LAM_1	STAB2 CELSR1 NTN5 USH2A	5.34e-05	30	130	4	PS01248
Domain	-	FLT1 LRRC4B PKHD1L1 NOMO1 HHLA2 TGM3 POMGNT2 UMODL1 NOMO2 ALPK3 LINGO4 LSAMP USH2A NOMO3 LILRA4	5.91e-05	663	130	15	2.60.40.10
Domain	CarboxyPept_regulatory_dom	NOMO1 NOMO2 NOMO3	8.96e-05	13	130	3	IPR014766
Domain	-	NOMO1 NOMO2 NOMO3	8.96e-05	13	130	3	2.60.40.1120
Domain	EGF_Lam	STAB2 CELSR1 NTN5 USH2A	9.93e-05	35	130	4	SM00180
Domain	GPS	PKD1L1 PKD1L2 ADGRG6 CELSR1	1.11e-04	36	130	4	PS50221
Domain	Ig-like_fold	FLT1 LRRC4B PKHD1L1 NOMO1 HHLA2 TGM3 POMGNT2 UMODL1 NOMO2 ALPK3 LINGO4 LSAMP USH2A NOMO3 LILRA4	1.19e-04	706	130	15	IPR013783
Domain	GPS	PKD1L1 PKD1L2 ADGRG6 CELSR1	1.24e-04	37	130	4	IPR000203
Domain	Laminin_EGF	STAB2 CELSR1 NTN5 USH2A	1.38e-04	38	130	4	IPR002049
Domain	SV2	SV2B SV2A	1.44e-04	3	130	2	IPR022308
Domain	Pentapeptide_4	SV2B SV2A	1.44e-04	3	130	2	PF13599
Domain	ConA-like_dom	LGALS9C LGALS9B COL5A3 ADGRG6 CELSR1 FAT2 LRBA USH2A	1.50e-04	219	130	8	IPR013320
Domain	Laminin_G_2	COL5A3 CELSR1 FAT2 USH2A	1.69e-04	40	130	4	PF02210
Domain	MFS_1	SLC43A1 SLC16A1 SLC18A1 SV2B SV2A	2.00e-04	77	130	5	PF07690
Domain	MFS	SLC43A1 SLC16A1 SLC18A1 SV2B SV2A	2.00e-04	77	130	5	IPR011701
Domain	CarboxyPept-like_regulatory	NOMO1 NOMO2 NOMO3	2.09e-04	17	130	3	IPR008969
Domain	LamG	COL5A3 CELSR1 FAT2 USH2A	2.45e-04	44	130	4	SM00282
Domain	5peptide_repeat	SV2B SV2A	2.86e-04	4	130	2	IPR001646
Domain	G8_domain	PKHD1L1 CEMIP2	2.86e-04	4	130	2	IPR019316
Domain	G8	PKHD1L1 CEMIP2	2.86e-04	4	130	2	PS51484
Domain	G8	PKHD1L1 CEMIP2	2.86e-04	4	130	2	SM01225
Domain	G8	PKHD1L1 CEMIP2	2.86e-04	4	130	2	PF10162
Domain	REJ	PKD1L1 PKD1L2	2.86e-04	4	130	2	PS51111
Domain	REJ_dom	PKD1L1 PKD1L2	2.86e-04	4	130	2	IPR014010
Domain	MFS_dom	SLC43A1 SLC2A3 SLC16A1 SLC18A1 SV2B SV2A	3.51e-04	134	130	6	IPR020846
Domain	PKD/REJ-like	PKD1L1 PKD1L2	7.08e-04	6	130	2	IPR002859
Domain	REJ	PKD1L1 PKD1L2	7.08e-04	6	130	2	PF02010
Domain	Laminin_G	COL5A3 CELSR1 FAT2 USH2A	7.11e-04	58	130	4	IPR001791
Domain	HECT	HUWE1 HERC2 SMURF2	8.53e-04	27	130	3	PF00632
Domain	HECTc	HUWE1 HERC2 SMURF2	8.53e-04	27	130	3	SM00119
Domain	HECT_dom	HUWE1 HERC2 SMURF2	8.53e-04	27	130	3	IPR000569
Domain	HECT	HUWE1 HERC2 SMURF2	8.53e-04	27	130	3	PS50237
Domain	MFS	SLC2A3 SLC16A1 SLC18A1 SV2B SV2A	9.51e-04	108	130	5	PS50850
Domain	ENTH_VHS	STAM2 TTI1 RPRD2	1.05e-03	29	130	3	IPR008942
Domain	Pectin_lyase_fold/virulence	PKHD1L1 CEMIP2	1.31e-03	8	130	2	IPR011050
Domain	PH-BEACH_dom	WDFY4 LRBA	1.31e-03	8	130	2	IPR023362
Domain	-	WDFY4 LRBA	1.31e-03	8	130	2	2.30.29.40
Domain	PH_BEACH	WDFY4 LRBA	1.31e-03	8	130	2	PS51783
Domain	Sugar_transporter_CS	SLC2A3 SV2B SV2A	1.41e-03	32	130	3	IPR005829
Domain	EGF_CA	STAB2 CELSR1 FAT2 UMODL1 LRP2	1.64e-03	122	130	5	SM00179
Domain	BEACH	WDFY4 LRBA	1.68e-03	9	130	2	PS50197
Domain	Beach	WDFY4 LRBA	1.68e-03	9	130	2	PF02138
Domain	-	WDFY4 LRBA	1.68e-03	9	130	2	1.10.1540.10
Domain	Beach	WDFY4 LRBA	1.68e-03	9	130	2	SM01026
Domain	BEACH_dom	WDFY4 LRBA	1.68e-03	9	130	2	IPR000409
Domain	GPS	PKD1L2 ADGRG6 CELSR1	1.68e-03	34	130	3	SM00303
Domain	EGF-like_Ca-bd_dom	STAB2 CELSR1 FAT2 UMODL1 LRP2	1.76e-03	124	130	5	IPR001881
Domain	GPS	PKD1L2 ADGRG6 CELSR1	1.83e-03	35	130	3	PF01825
Domain	Laminin_EGF	CELSR1 NTN5 USH2A	1.83e-03	35	130	3	PF00053
Domain	MFS_sugar_transport-like	SLC2A3 SV2B SV2A	1.99e-03	36	130	3	IPR005828
Domain	Sugar_tr	SLC2A3 SV2B SV2A	1.99e-03	36	130	3	PF00083
Domain	EGF_1	STAB2 CELSR1 FAT2 UMODL1 NTN5 LRP2 USH2A	2.07e-03	255	130	7	PS00022
Domain	EMI	EMILIN1 UMODL1	2.09e-03	10	130	2	PF07546
Domain	-	KIF21A TAF1C WDR37 WDFY4 DENND3 STRN4 NUP133 LRBA	2.32e-03	333	130	8	2.130.10.10
Domain	LAM_G_DOMAIN	CELSR1 FAT2 USH2A	2.33e-03	38	130	3	PS50025
Domain	WD40/YVTN_repeat-like_dom	KIF21A TAF1C WDR37 WDFY4 DENND3 STRN4 NUP133 LRBA	2.41e-03	335	130	8	IPR015943
Domain	PKD_channel	PKD1L1 PKD1L2	2.54e-03	11	130	2	PF08016
Domain	PKD1_2_channel	PKD1L1 PKD1L2	2.54e-03	11	130	2	IPR013122
Domain	WD40_repeat	KIF21A WDR37 WDFY4 DENND3 STRN4 LRBA HERC2	2.97e-03	272	130	7	IPR001680
Domain	ABC_A	ABCA2 ABCA9	3.03e-03	12	130	2	IPR026082
Domain	WD_REPEATS_1	KIF21A WDR37 WDFY4 DENND3 STRN4 LRBA HERC2	3.35e-03	278	130	7	PS00678
Domain	AAA	ABCC3 ABCA2 MCM7 ABCA9 NAV1	3.36e-03	144	130	5	SM00382
Domain	AAA+_ATPase	ABCC3 ABCA2 MCM7 ABCA9 NAV1	3.36e-03	144	130	5	IPR003593
Domain	WD_REPEATS_2	KIF21A WDR37 WDFY4 DENND3 STRN4 LRBA HERC2	3.42e-03	279	130	7	PS50082
Domain	WD_REPEATS_REGION	KIF21A WDR37 WDFY4 DENND3 STRN4 LRBA HERC2	3.42e-03	279	130	7	PS50294
Domain	-	MRC2 MMP9	3.57e-03	13	130	2	2.10.10.10
Domain	FN_type2_col-bd	MRC2 MMP9	4.14e-03	14	130	2	IPR000562
Domain	FN2_2	MRC2 MMP9	4.14e-03	14	130	2	PS51092
Domain	FN2_1	MRC2 MMP9	4.14e-03	14	130	2	PS00023
Domain	fn2	MRC2 MMP9	4.14e-03	14	130	2	PF00040
Domain	FN2	MRC2 MMP9	4.14e-03	14	130	2	SM00059
Domain	ABC_tran	ABCC3 ABCA2 ABCA9	4.53e-03	48	130	3	PF00005
Domain	ABC_TRANSPORTER_2	ABCC3 ABCA2 ABCA9	4.53e-03	48	130	3	PS50893
Domain	Kinase-like_dom	RAF1 FLT1 ERBB3 ERN1 HUNK TEX14 TRRAP TTBK1 ALPK3 MASTL	4.64e-03	542	130	10	IPR011009
Domain	Growth_fac_rcpt_	ERBB3 STAB2 CELSR1 UMODL1 LRP2	4.73e-03	156	130	5	IPR009030
Domain	Galectin_CRD	LGALS9C LGALS9B	4.76e-03	15	130	2	IPR001079
Domain	Gal-bind_lectin	LGALS9C LGALS9B	4.76e-03	15	130	2	PF00337
Domain	Gal-bind_lectin	LGALS9C LGALS9B	4.76e-03	15	130	2	SM00908
Domain	GALECTIN	LGALS9C LGALS9B	4.76e-03	15	130	2	PS51304
Domain	GLECT	LGALS9C LGALS9B	4.76e-03	15	130	2	SM00276
Domain	WD40_repeat_dom	KIF21A TAF1C WDR37 WDFY4 DENND3 STRN4 LRBA	4.80e-03	297	130	7	IPR017986
Domain	CUB	ADGRG6 LRP3 CSMD1	4.81e-03	49	130	3	PF00431
Domain	ABC_TRANSPORTER_1	ABCC3 ABCA2 ABCA9	4.81e-03	49	130	3	PS00211
Domain	ABC_transporter-like	ABCC3 ABCA2 ABCA9	5.09e-03	50	130	3	IPR003439
Domain	CUB	ADGRG6 LRP3 CSMD1	5.09e-03	50	130	3	SM00042
Domain	EMI_domain	EMILIN1 UMODL1	5.41e-03	16	130	2	IPR011489
Domain	-	ADGRG6 LRP3 CSMD1	5.68e-03	52	130	3	2.60.120.290
Domain	WD40_repeat_CS	KIF21A WDR37 WDFY4 DENND3 STRN4	5.83e-03	164	130	5	IPR019775
Domain	CUB	ADGRG6 LRP3 CSMD1	5.99e-03	53	130	3	PS01180
Domain	IGc2	FLT1 LRRC4B ALPK3 LINGO4 LSAMP LILRA4	6.08e-03	235	130	6	SM00408
Domain	Ig_sub2	FLT1 LRRC4B ALPK3 LINGO4 LSAMP LILRA4	6.08e-03	235	130	6	IPR003598
Domain	EMI	EMILIN1 UMODL1	6.11e-03	17	130	2	PS51041
Domain	LH2	PKD1L1 PKD1L2	6.84e-03	18	130	2	SM00308
Pubmed	Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration.	NOMO1 NOMO2 NOMO3	5.72e-08	3	135	3	36011023
Pubmed	Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes.	NOMO1 NOMO2 NOMO3	5.72e-08	3	135	3	25576386
Pubmed	Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology.	NOMO1 NOMO2 NOMO3	2.28e-07	4	135	3	31833031
Pubmed	A locus for autosomal recessive pseudoxanthoma elasticum, with penetrance of vascular symptoms in carriers, maps to chromosome 16p13.1.	NOMO1 NOMO2 NOMO3	2.28e-07	4	135	3	9267806
Pubmed	Serial transplantation unmasks galectin-9 contribution to tumor immune escape in the MB49 murine model.	LGALS9C LGALS9B CXCL10	5.69e-07	5	135	3	33664349
Pubmed	CLEC16A interacts with retromer and TRIM27, and its loss impairs endosomal trafficking and neurodevelopment.	RAF1 MARCHF7 HUWE1 NOMO1 CEP170 NOMO2 STRN4 NUP133 TIMM17A TTI1 HERC2 SLC25A19 NOMO3	7.55e-07	606	135	13	36538041
Pubmed	Nicalin and its binding partner Nomo are novel Nodal signaling antagonists.	NOMO1 NOMO2 NOMO3	3.16e-06	8	135	3	15257293
Pubmed	Blood-Brain Barrier: From Physiology to Disease and Back.	ABCC3 ABCA2 SLC13A3 SLC16A1 LRP2 LRP3	3.59e-06	105	135	6	30280653
Pubmed	Substrate-driven assembly of a translocon for multipass membrane proteins.	NOMO1 NOMO2 NOMO3	4.72e-06	9	135	3	36261522
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	TPCN2 HUWE1 WDR37 TRRAP ADCY1 BDH1 DNAH14 ADGRG6 GMPS CEP170 NAV1 RPRD2 LRBA ARHGEF37 CSMD1 DNAJC3 SMURF2 CRAMP1 VPS13B	5.15e-06	1489	135	19	28611215
Pubmed	Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.	MCM7 HUWE1 CEMIP2 ADGRG6 NOMO1 GMPS POMGNT2 NOMO2 MRC2 NUP133 TTI1 NOMO3	5.22e-06	613	135	12	22268729
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ABCC3 CRYBG2 ABCA2 HUWE1 TRRAP CABLES1 SLC52A3 CELSR1 POMGNT2 STRN4 NAV1 LRP3 LRBA HERC2 SMURF2 CRAMP1	6.48e-06	1105	135	16	35748872
Pubmed	LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.	LGALS9C LGALS9B HUWE1 TRRAP NOMO1 GMPS NOMO2 NOMO3 MOV10	8.55e-06	344	135	9	30333137
Pubmed	An ER translocon for multi-pass membrane protein biogenesis.	NOMO1 NOMO2 NOMO3	9.22e-06	11	135	3	32820719
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	STAM2 HBS1L MCM7 HUWE1 TRRAP CEP170 SLC16A1 SEC24B STRN4 RPRD2 LRBA	1.05e-05	549	135	11	38280479
Pubmed	Polycystin-1L2 is a novel G-protein-binding protein.	PKD1L1 PKD1L2	1.50e-05	2	135	2	15203210
Pubmed	SV2 renders primed synaptic vesicles competent for Ca2+ -induced exocytosis.	SV2B SV2A	1.50e-05	2	135	2	19176798
Pubmed	Synaptic vesicle protein 2 binds adenine nucleotides.	SV2B SV2A	1.50e-05	2	135	2	18524768
Pubmed	Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytes.	CXCL10 MMP9	1.50e-05	2	135	2	27637385
Pubmed	Rb-Raf-1 interaction disruptor RRD-251 induces apoptosis in metastatic melanoma cells and synergizes with dacarbazine.	RAF1 RB1	1.50e-05	2	135	2	21139044
Pubmed	Downregulation of Smurf2, a tumor-suppressive ubiquitin ligase, in triple-negative breast cancers: involvement of the RB-microRNA axis.	RB1 SMURF2	1.50e-05	2	135	2	24485087
Pubmed	Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons.	SV2B SV2A	1.50e-05	2	135	2	18815274
Pubmed	Brain contains two forms of synaptic vesicle protein 2.	SV2B SV2A	1.50e-05	2	135	2	7681585
Pubmed	A Key Role of DNA Damage-Inducible Transcript 4 (DDIT4) Connects Autophagy and GLUT3-Mediated Stemness To Desensitize Temozolomide Efficacy in Glioblastomas.	DDIT4 SLC2A3	1.50e-05	2	135	2	31916238
Pubmed	SV2 mediates entry of tetanus neurotoxin into central neurons.	SV2B SV2A	1.50e-05	2	135	2	21124874
Pubmed	The COL5A3 and MMP9 genes interact in eczema susceptibility.	COL5A3 MMP9	1.50e-05	2	135	2	29168291
Pubmed	A small molecule disruptor of Rb/Raf-1 interaction inhibits cell proliferation, angiogenesis, and growth of human tumor xenografts in nude mice.	RAF1 RB1	1.50e-05	2	135	2	18483265
Pubmed	The value of matrix metalloproteinase-9 and vascular endothelial growth factor receptor 1 pathway in diagnosing indeterminate pleural effusion.	FLT1 MMP9	1.50e-05	2	135	2	23190621
Pubmed	SV2 regulates neurotransmitter release via multiple mechanisms.	SV2B SV2A	1.50e-05	2	135	2	20702688
Pubmed	Synaptic vesicle protein 2 enhances release probability at quiescent synapses.	SV2B SV2A	1.50e-05	2	135	2	16436618
Pubmed	Altered balance between excitatory and inhibitory inputs onto CA1 pyramidal neurons from SV2A-deficient but not SV2B-deficient mice.	SV2B SV2A	1.50e-05	2	135	2	22847229
Pubmed	Megalin (gp330): a putative endocytic receptor for thyroglobulin (Tg).	TG LRP2	1.50e-05	2	135	2	9492085
Pubmed	Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A).	SV2B SV2A	1.50e-05	2	135	2	10611374
Pubmed	VEGFR-1 activation-induced MMP-9-dependent invasion in hepatocellular carcinoma.	FLT1 MMP9	1.50e-05	2	135	2	26551737
Pubmed	SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release.	SV2B SV2A	1.50e-05	2	135	2	10624962
Pubmed	Circular rapid amplification of cDNA ends for high-throughput extension cloning of partial genes.	CRYBG2 ABCA2 TPCN2 HERC2 CSMD1	1.97e-05	84	135	5	15203218
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	HBS1L RB1 KIF21A TAF1C ADNP2 DGKD MCM7 HUWE1 TRRAP GMPS TGM3 FBXL18 SLC16A1 SEC24B NUP133 HERC2 MOV10	2.06e-05	1353	135	17	29467282
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	HBS1L DGKD WDFY4 DENND3 NCOA5 CEP170 FAT2 TTBK1 LMBR1L MOV10	2.43e-05	493	135	10	15368895
Pubmed	Defective neuromuscular synaptogenesis in agrin-deficient mutant mice.	ERBB3 SV2B SV2A	4.47e-05	18	135	3	8653788
Pubmed	Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation.	LGALS9C LGALS9B	4.48e-05	3	135	2	19776007
Pubmed	Galectin-9 regulates follicular helper T cells to inhibit humoral autoimmunity-induced pulmonary fibrosis.	LGALS9C LGALS9B	4.48e-05	3	135	2	33316546
Pubmed	Identification and characterization of galectin-9, a novel beta-galactoside-binding mammalian lectin.	LGALS9C LGALS9B	4.48e-05	3	135	2	9038233
Pubmed	Expression pattern of synaptic vesicle protein 2 (SV2) isoforms in patients with temporal lobe epilepsy and hippocampal sclerosis.	SV2B SV2A	4.48e-05	3	135	2	23617838
Pubmed	RB reversibly inhibits DNA replication via two temporally distinct mechanisms.	RB1 MCM7	4.48e-05	3	135	2	15169903
Pubmed	Protective effect of Galectin-9 in murine model of lung emphysema: Involvement of neutrophil migration and MMP-9 production.	LGALS9C LGALS9B	4.48e-05	3	135	2	28704475
Pubmed	Galectin-9 protein is up-regulated in astrocytes by tumor necrosis factor and promotes encephalitogenic T-cell apoptosis.	LGALS9C LGALS9B	4.48e-05	3	135	2	23836896
Pubmed	Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes.	LGALS9C LGALS9B	4.48e-05	3	135	2	7890611
Pubmed	Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner.	LGALS9C LGALS9B	4.48e-05	3	135	2	22341088
Pubmed	Galectin-9 Is a Novel Regulator of Epithelial Restitution.	LGALS9C LGALS9B	4.48e-05	3	135	2	32380082
Pubmed	Galectin-9-mediated protection from allo-specific T cells as a mechanism of immune privilege of corneal allografts.	LGALS9C LGALS9B	4.48e-05	3	135	2	23667648
Pubmed	Regulatory T Cell-Mediated Suppression of Inflammation Induced by DR3 Signaling Is Dependent on Galectin-9.	LGALS9C LGALS9B	4.48e-05	3	135	2	28877989
Pubmed	Oct-1 maintains an intermediate, stable state of HLA-DRA promoter repression in Rb-defective cells: an Oct-1-containing repressosome that prevents NF-Y binding to the HLA-DRA promoter.	RB1 POU2F1	4.48e-05	3	135	2	15105429
Pubmed	Galectin-9 ameliorates immune complex-induced arthritis by regulating Fc gamma R expression on macrophages.	LGALS9C LGALS9B	4.48e-05	3	135	2	19800850
Pubmed	The effect of Toxoplasma gondii infection on galectin-9 expression in decidual macrophages contributing to dysfunction of decidual NK cells during pregnancy.	LGALS9C LGALS9B	4.48e-05	3	135	2	38987795
Pubmed	Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapy.	LGALS9C LGALS9B	4.48e-05	3	135	2	37105392
Pubmed	Galectin-9/Tim-3 pathway mediates dopaminergic neurodegeneration in MPTP-induced mouse model of Parkinson's disease.	LGALS9C LGALS9B	4.48e-05	3	135	2	36479526
Pubmed	Profiling Lgals9 splice variant expression at the fetal-maternal interface: implications in normal and pathological human pregnancy.	LGALS9C LGALS9B	4.48e-05	3	135	2	23242525
Pubmed	Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice.	LGALS9C LGALS9B	4.48e-05	3	135	2	19851072
Pubmed	The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes.	LGALS9C LGALS9B	4.48e-05	3	135	2	33923930
Pubmed	Expression of SV2 isoforms during rodent brain development.	SV2B SV2A	4.48e-05	3	135	2	23937191
Pubmed	HIV gp120 binds to mannose receptor on vaginal epithelial cells and induces production of matrix metalloproteinases.	MRC2 MMP9	4.48e-05	3	135	2	22132194
Pubmed	Overlapping functions of stonin 2 and SV2 in sorting of the calcium sensor synaptotagmin 1 to synaptic vesicles.	SV2B SV2A	4.48e-05	3	135	2	26015569
Pubmed	Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases.	LGALS9C LGALS9B	4.48e-05	3	135	2	31969388
Pubmed	Effect of HPV on tumor expression levels of the most commonly used markers in HNSCC.	FLT1 MMP9	4.48e-05	3	135	2	26666815
Pubmed	Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia.	LGALS9C LGALS9B	4.48e-05	3	135	2	35241678
Pubmed	Differentiation of two human neuroblastoma cell lines alters SV2 expression patterns.	SV2B SV2A	4.48e-05	3	135	2	33588752
Pubmed	Cell cycle arrest by transforming growth factor beta1 near G1/S is mediated by acute abrogation of prereplication complex activation involving an Rb-MCM interaction.	RB1 MCM7	4.48e-05	3	135	2	19948884
Pubmed	Possible regulatory role of galectin-9 on Ascaris suum-induced eosinophilic lung inflammation in mice.	LGALS9C LGALS9B	4.48e-05	3	135	2	22627368
Pubmed	BVVL/ FL: features caused by SLC52A3 mutations; WDFY4 and TNFSF13B may be novel causative genes.	WDFY4 SLC52A3	4.48e-05	3	135	2	33189404
Pubmed	Galectin-9 is required for endometrial regenerative cells to induce long-term cardiac allograft survival in mice.	LGALS9C LGALS9B	4.48e-05	3	135	2	33153471
Pubmed	T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses.	LGALS9C LGALS9B	4.48e-05	3	135	2	22052881
Pubmed	Mapping of the motor neuron degeneration (Mnd) gene, a mouse model of amyotrophic lateral sclerosis (ALS).	ANK1 POLB	4.48e-05	3	135	2	1639406
Pubmed	Synaptic Vesicle Protein 2 and Vesicular Monoamine Transporter 1 and 2 Are Expressed in Neuroblastoma.	SLC18A1 SV2A	4.48e-05	3	135	2	31317476
Pubmed	Galectin-9 supports primary T cell transendothelial migration in a glycan and integrin dependent manner.	LGALS9C LGALS9B	4.48e-05	3	135	2	35643073
Pubmed	Direct recording and molecular identification of the calcium channel of primary cilia.	PKD1L1 PKD1L2	4.48e-05	3	135	2	24336289
Pubmed	Galectin-9 functionally impairs natural killer cells in humans and mice.	LGALS9C LGALS9B	4.48e-05	3	135	2	23408620
Pubmed	MMP-9 Inhibition Suppresses Interferon-γ-Induced CXCL10 Production in Human Salivary Gland Ductal Cells.	CXCL10 MMP9	4.48e-05	3	135	2	31440939
Pubmed	Galectin-9 Is Critical for Mucosal Adaptive Immunity through the T Helper 17-IgA Axis.	LGALS9C LGALS9B	4.48e-05	3	135	2	29458010
Pubmed	Raf-1 physically interacts with Rb and regulates its function: a link between mitogenic signaling and cell cycle regulation.	RAF1 RB1	4.48e-05	3	135	2	9819434
Pubmed	Cooperative Interactions of Oligosaccharide and Peptide Moieties of a Glycopeptide Derived from IgE with Galectin-9.	LGALS9C LGALS9B	4.48e-05	3	135	2	26582205
Pubmed	Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin.	LGALS9C LGALS9B	4.48e-05	3	135	2	9153289
Pubmed	Galectin-9 expands unique macrophages exhibiting plasmacytoid dendritic cell-like phenotypes that activate NK cells in tumor-bearing mice.	LGALS9C LGALS9B	4.48e-05	3	135	2	18974023
Pubmed	Cell surface galectin-9 expressing Th cells regulate Th17 and Foxp3+ Treg development by galectin-9 secretion.	LGALS9C LGALS9B	4.48e-05	3	135	2	23144904
Pubmed	Impaired Gal-9 Dysregulates the PBMC-Induced Th1/Th2 Imbalance in Abortion-Prone Matings.	LGALS9C LGALS9B	4.48e-05	3	135	2	29651447
Pubmed	The N- and C-terminal carbohydrate recognition domains of galectin-9 contribute differently to its multiple functions in innate immunity and adaptive immunity.	LGALS9C LGALS9B	4.48e-05	3	135	2	21146220
Pubmed	Regulation of M1‑type and M2‑type macrophage polarization in RAW264.7 cells by Galectin‑9.	LGALS9C LGALS9B	4.48e-05	3	135	2	28990062
Pubmed	Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices.	LGALS9C LGALS9B	4.48e-05	3	135	2	18579572
Pubmed	M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis.	FLT1 MMP9	4.48e-05	3	135	2	19398755
Pubmed	Crystal structure of the galectin-9 N-terminal carbohydrate recognition domain from Mus musculus reveals the basic mechanism of carbohydrate recognition.	LGALS9C LGALS9B	4.48e-05	3	135	2	16990264
Pubmed	Structural analysis of the human galectin-9 N-terminal carbohydrate recognition domain reveals unexpected properties that differ from the mouse orthologue.	LGALS9C LGALS9B	4.48e-05	3	135	2	18005988
Pubmed	Galectin-9 ameliorates clinical severity of MRL/lpr lupus-prone mice by inducing plasma cell apoptosis independently of Tim-3.	LGALS9C LGALS9B	4.48e-05	3	135	2	23585851
Pubmed	Galectin-9 ameliorates anti-GBM glomerulonephritis by inhibiting Th1 and Th17 immune responses in mice.	LGALS9C LGALS9B	4.48e-05	3	135	2	24477688
Pubmed	A unique role for galectin-9 in angiogenesis and inflammatory arthritis.	LGALS9C LGALS9B	4.48e-05	3	135	2	29433546
Pubmed	No major role of common SV2A variation for predisposition or levetiracetam response in epilepsy.	SV2B SV2A	4.48e-05	3	135	2	18977120
Pubmed	Enhanced susceptibility to chemically induced colitis caused by excessive endosomal TLR signaling in LRBA-deficient mice.	UNC93B1 LRBA	4.48e-05	3	135	2	31097594
Pubmed	CCL2 increases MMP-9 expression and cell motility in human chondrosarcoma cells via the Ras/Raf/MEK/ERK/NF-κB signaling pathway.	RAF1 MMP9	4.48e-05	3	135	2	22138288
Pubmed	SV2 is the protein receptor for botulinum neurotoxin A.	SV2B SV2A	4.48e-05	3	135	2	16543415
Pubmed	Differential distribution and developmental expression of synaptic vesicle protein 2 isoforms in the mouse retina.	SV2B SV2A	4.48e-05	3	135	2	12687700
Pubmed	Alarmin function of galectin-9 in murine respiratory tularemia.	LGALS9C LGALS9B	4.48e-05	3	135	2	25898318
Pubmed	SV2 modulates the size of the readily releasable pool of secretory vesicles.	SV2B SV2A	4.48e-05	3	135	2	11483953
Interaction	BRICD5 interactions	ABCA2 ADGRG6 NOMO1 HHLA2 CELSR1 POMGNT2 SLC18A1 DNAJC3 NOMO3	4.19e-06	194	128	9	int:BRICD5
Interaction	NOMO2 interactions	RAF1 HUWE1 NOMO2 DNAJC3 MOV10	5.96e-06	41	128	5	int:NOMO2
Interaction	SCAP interactions	TRRAP NOMO1 LMBR1L SEC24B UPK3BL1 MOV10 SLC27A3	1.22e-05	121	128	7	int:SCAP
Interaction	TAFA4 interactions	ITGA8 LRRC4B POMGNT2 MRC2 LRP2	2.58e-05	55	128	5	int:TAFA4
Cytoband	9q33.2	B3GALT9 OR1L6 OR1K1	2.10e-04	39	135	3	9q33.2
GeneFamily	Solute carriers	SLC43A1 SLC34A2 SLC13A3 SLC2A3 SLC52A3 SLC16A1 SLC18A1 SLC25A19 SLC27A3	1.41e-04	395	89	9	752
GeneFamily	WD repeat domain containing\|BEACH domain containing	WDFY4 LRBA	8.43e-04	9	89	2	1230
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	FLT1 LRRC4B ALPK3 LINGO4 LSAMP	1.20e-03	161	89	5	593
GeneFamily	Low density lipoprotein receptors	LRP2 LRP3	1.80e-03	13	89	2	634
GeneFamily	WD repeat domain containing	KIF21A WDR37 WDFY4 DENND3 STRN4 LRBA	1.86e-03	262	89	6	362
GeneFamily	ATP binding cassette subfamily A	ABCA2 ABCA9	2.10e-03	14	89	2	805
GeneFamily	Galectins	LGALS9C LGALS9B	2.41e-03	15	89	2	629
GeneFamily	Wiskott-Aldrich Syndrome protein family	WASHC1 WASH2P	2.75e-03	16	89	2	14
Coexpression	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP	DDIT4 ITGA8 SLC2A3 NOMO1 NOMO2 NAV1 TIMM17A NOMO3	4.62e-06	185	132	8	MM1115
Coexpression	VANTVEER_BREAST_CANCER_POOR_PROGNOSIS	FLT1 SLC2A3 ADGRG6 GMPS MMP9	4.79e-06	49	132	5	M14693
Coexpression	VANTVEER_BREAST_CANCER_METASTASIS_DN	FLT1 KIF21A SLC2A3 ADGRG6 GMPS MMP9	1.93e-05	109	132	6	M9826
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ARHGAP15 ITGA8 CPED1 EMILIN1 ABCA9 MRC2 LSAMP	1.22e-07	190	135	8	2306aa9dbeaef3be8484a5b236605de23cd75d4c
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ARHGAP15 ITGA8 CPED1 EMILIN1 ABCA9 MRC2 LSAMP	1.22e-07	190	135	8	1f83f7f24288a3b9ab33c2e113e845dba96adc8a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ARHGAP15 ITGA8 CPED1 EMILIN1 ABCA9 MRC2 LSAMP	1.27e-07	191	135	8	a58c75e9580139fb370b498d95660f10f3a2a27b
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ARHGAP15 ITGA8 CPED1 EMILIN1 ABCA9 MRC2 LSAMP	1.49e-07	195	135	8	d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ITGA8 CPED1 EMILIN1 ABCA9 SLC2A3 MRC2 LSAMP	1.49e-07	195	135	8	44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ARHGAP15 ITGA8 CPED1 EMILIN1 ABCA9 MRC2 LSAMP	1.61e-07	197	135	8	6d027119a5f7ca2aac1b10837e43f9a2bb54db85
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ARHGAP15 ITGA8 CPED1 EMILIN1 ABCA9 MRC2 LSAMP	1.61e-07	197	135	8	b349f8e96d61a4c296af64711e11fc44459a9413
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ARHGAP15 ITGA8 CPED1 EMILIN1 ABCA9 MRC2 LSAMP	1.61e-07	197	135	8	c2e390653d5dee7e731c1840cfdab41987dede9b
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAB2 ANK1 PKD1L2 PKHD1L1 LRP2 CSMD1 USH2A	1.52e-06	184	135	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAB2 ANK1 PKD1L2 PKHD1L1 LRP2 CSMD1 USH2A	1.52e-06	184	135	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAB2 ANK1 PKD1L2 PKHD1L1 LRP2 CSMD1 USH2A	1.52e-06	184	135	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ITGA8 CPED1 EMILIN1 ABCA9 MRC2 LSAMP	2.02e-06	192	135	7	9093a9e94a25682d109a7f6edc256a25a61103a0
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ITGA8 CPED1 EMILIN1 ABCA9 MRC2 LSAMP	2.02e-06	192	135	7	9ed5d49621ec1aa01716dc369bba1450b5f015f5
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ITGA8 CPED1 EMILIN1 ABCA9 MRC2 LSAMP	2.09e-06	193	135	7	f1199518c3626fd29bfce65070dd21a660671213
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ITGA8 CPED1 EMILIN1 SLC2A3 MRC2 LSAMP	2.16e-06	194	135	7	240d122dcb9dd1ab2867503ad85869853adcacae
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ITGA8 CPED1 EMILIN1 SLC2A3 MRC2 LSAMP	2.16e-06	194	135	7	ae7df037592f1c20c9d32be15fe6fc3c562ebeb1
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ARHGAP15 CPED1 EMILIN1 ABCA9 MRC2 LSAMP	2.16e-06	194	135	7	e03ba6caed59fa64d4d9b042593469d4a6a3dc10
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ARHGAP15 ITGA8 CPED1 EMILIN1 ABCA9 MRC2	2.24e-06	195	135	7	edd4cd8402af81737b2074f9dce71cc6ab09be7e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ARHGAP15 CPED1 ABCA9 MRC2 NAV1 LSAMP	2.24e-06	195	135	7	3c3703f092b6fc1b7333426fb5e2823bfb74bb57
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ITGA8 CPED1 EMILIN1 ABCA9 MRC2 LSAMP	2.31e-06	196	135	7	ba869f7a86f37fd6d84d6ad69baca0e0faaf5887
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ITGA8 CPED1 EMILIN1 ABCA9 MRC2 LSAMP	2.31e-06	196	135	7	30ad56d49000e4ddce73b4443b3994564bd1e2d6
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ARHGAP15 ITGA8 CPED1 ABCA9 MRC2 LSAMP	2.39e-06	197	135	7	80e153790cef37b743e22a7370ff5b3a6abf147d
ToppCell	Substantia_nigra-Endothelial-ENDOTHELIAL_TIP\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	SLC43A1 SLC13A3 CPED1 EMILIN1 ABCA9 MRC2	9.14e-06	159	135	6	cb2470b288c13e454a2a80115b0d5613b3f718e6
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC1-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ERN1 POLB SLC34A2 WDFY4 FBXL18 LILRA4	1.17e-05	166	135	6	c8a7d94ed762e5e045ab5f74eef691ddc5f74993
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FLT1 LGALS9B ITGA8 PKHD1L1 ADCY1 NAV1	1.29e-05	169	135	6	987ff79ad563825dd9877ea8ccb536758f8c6700
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TRERF1 FLT1 WDR37 CEMIP2 ADGRG6 SLC52A3	1.29e-05	169	135	6	f086b50791e1c93e253eb5e8d6c4bf617b1416c3
ToppCell	facs-Heart-LV-3m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CXCL10 HUNK CPED1 PKHD1L1 CEMIP2 LRRC9	1.43e-05	172	135	6	f2c17c49b375b28ad47dc6cabda62f1c238023dd
ToppCell	facs-Heart-LV-3m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CXCL10 HUNK CPED1 PKHD1L1 CEMIP2 LRRC9	1.43e-05	172	135	6	6ab4f01098dddb789df298ddf97b3c384405ee6c
ToppCell	normal_Lymph_Node-Myeloid_cells-pDCs\|Myeloid_cells / Location, Cell class and cell subclass	TRERF1 ANK1 POLB NOMO1 LRBA LILRA4	1.53e-05	174	135	6	2274648b80dd74f3c948a779bba3391095964c34
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	ABCC3 DDIT4 SLC2A3 SLC52A3 TTI1 RPRD2	1.74e-05	178	135	6	be4976bbfd9ebbc568155ede99a07670c43aa372
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	ABCC3 DDIT4 SLC2A3 SLC52A3 TTI1 RPRD2	1.74e-05	178	135	6	91bf3c7c05d2e67ee590389a1b36c517d0ed7ebf
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DDIT4 FLT1 DENND3 CEMIP2 ADGRG6 NAV1	1.91e-05	181	135	6	4d7793026373cbcf04b15c77f95f1025d07d4c00
ToppCell	Control-Myeloid-DC1\|Control / Condition, Lineage and Cell class	CRYBG2 WDFY4 ADCY1 ADGRG6 MRC2 NAV1	1.91e-05	181	135	6	5a2a1f017ad23baed9972c68b4a46f4c618ef21a
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ARHGAP15 CPED1 ABCA9 SLC2A3 LSAMP	1.97e-05	182	135	6	44764676ed3f51ba171ce63f669390392fa50a43
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ARHGAP15 CPED1 ABCA9 SLC2A3 LSAMP	1.97e-05	182	135	6	d82f59a3f930a840dde27dc6ab024f227a26d446
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DDIT4 FLT1 DENND3 CEMIP2 ADGRG6 NAV1	2.03e-05	183	135	6	3427f3cbe6ea81709750e7dd3ff378f03ae65eab
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ARHGAP15 COL5A3 CPED1 ABCA9 MRC2	2.09e-05	184	135	6	c5436a8e45f471b8d1301abbe9c7879204537f52
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC3 SLC34A2 SLC13A3 HHLA2 CELSR1 LRP2	2.22e-05	186	135	6	b1edc341d6684b347dc9e21b34f62f51d095d735
ToppCell	droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC43A1 COL5A3 PKHD1L1 ABCA9 MRC2 LRP2	2.29e-05	187	135	6	4e553721fa5598cb211f44e3226280b7e6885484
ToppCell	droplet-Pancreas-Exocrine-18m-Mesenchymal\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC43A1 COL5A3 PKHD1L1 ABCA9 MRC2 LRP2	2.29e-05	187	135	6	d36e7fc6125e7a4310499365022d38f34b757a73
ToppCell	droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC43A1 COL5A3 PKHD1L1 ABCA9 MRC2 LRP2	2.29e-05	187	135	6	827eae63fabf6892a82ce7779b5f395958d3d628
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ARHGAP15 CPED1 EMILIN1 ABCA9 MRC2	2.43e-05	189	135	6	71397e993a77d70b2eeede240bdfc7660b558987
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ARHGAP15 CPED1 EMILIN1 ABCA9 MRC2	2.43e-05	189	135	6	4eea4759520c312bd17a681034d8074e47093d2b
ToppCell	RA-10._Endothelium_II\|World / Chamber and Cluster_Paper	FLT1 ITGA8 PKHD1L1 CEMIP2 ADGRG6 LSAMP	2.43e-05	189	135	6	75c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCell	RA-10._Endothelium_II\|RA / Chamber and Cluster_Paper	FLT1 ITGA8 PKHD1L1 CEMIP2 ADGRG6 LSAMP	2.43e-05	189	135	6	c81787a8c662db5d7814c583dd64562857629e81
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ITGA8 CPED1 ABCA9 MRC2 LSAMP	2.51e-05	190	135	6	2e592323085ba9c019d678ac2a784462ab470ed9
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ITGA8 CPED1 ABCA9 MRC2 LSAMP	2.51e-05	190	135	6	445952b70abffadb6ccc1ed4bbf61a88b06b73b3
ToppCell	facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 STAB2 EMILIN1 DENND3 CEMIP2 NAV1	2.66e-05	192	135	6	2bfac6b3956265205ca47d06888851ed68b65999
ToppCell	BAL-Mild\|BAL / Compartment, Disease Groups and Clusters	GBP7 LGALS9B CXCL10 PIWIL4 MASTL MOV10	2.66e-05	192	135	6	1a6cbf014d3f7a3fb6f53adab078c4742e7137de
ToppCell	facs-Liver-Non-hepatocytes-24m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 STAB2 EMILIN1 DENND3 CEMIP2 NAV1	2.66e-05	192	135	6	d525f7f088a53110912600a7c9f6d33b9270d534
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 CPED1 EMILIN1 ABCA9 SLC2A3 MRC2	2.74e-05	193	135	6	c8c21eee8c6c086dc2faf416669cd4a002870fbe
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 CPED1 EMILIN1 ABCA9 SLC2A3 MRC2	2.74e-05	193	135	6	5b602b1702283184bd3943c2a6f2290b7c37e407
ToppCell	COVID-19-kidney-FLT1+PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	DDIT4 FLT1 ITGA8 DENND3 SLC2A3 NAV1	2.74e-05	193	135	6	479abb1cd2eb978b8a4fdb900069a6329fc8cade
ToppCell	facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 STAB2 EMILIN1 DENND3 CEMIP2 NAV1	2.82e-05	194	135	6	c8b9551b93a5aed62154b487db90130604a6125c
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ARHGAP15 CPED1 EMILIN1 ABCA9 MRC2	2.82e-05	194	135	6	81713e0409e8be695ba5dfdc67a997b33435dd9e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ARHGAP15 CPED1 EMILIN1 ABCA9 MRC2	2.82e-05	194	135	6	cf0244a29934e515446ac917d3c30672b460fb04
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ARHGAP15 CPED1 EMILIN1 ABCA9 MRC2	2.82e-05	194	135	6	ba7f971fb9a19423602da60770f23d9fead4a451
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ARHGAP15 CPED1 EMILIN1 ABCA9 MRC2	2.82e-05	194	135	6	627cffe2d448e74fc5df92e74e5b922a73304137
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ITGA8 CPED1 EMILIN1 MRC2 LSAMP	2.90e-05	195	135	6	d8ebb94f30d4a655d6b29dd6a3076be2403d2356
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 CPED1 EMILIN1 ABCA9 SLC2A3 MRC2	2.90e-05	195	135	6	cad6563cc51d212554152c727fc2c249c6a07e4d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 CPED1 EMILIN1 ABCA9 SLC2A3 MRC2	2.90e-05	195	135	6	783bfa8110161cbd6def50ce849cae676c39c458
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 CPED1 EMILIN1 ABCA9 MRC2 LSAMP	2.98e-05	196	135	6	a12dd986df65c36f248cf10815c3b8b6238613b0
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ARHGAP15 CPED1 ABCA9 MRC2 LSAMP	2.98e-05	196	135	6	2b36b9a40fe415917afccff99ad9c3474e087d0d
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 CPED1 EMILIN1 ABCA9 MRC2 LSAMP	2.98e-05	196	135	6	3e6803587d8566fd08cb8b290be3b6461743d79c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 CPED1 EMILIN1 ABCA9 SLC2A3 MRC2	3.07e-05	197	135	6	09946ee8dfb15a2a32da06e5b331f3277ee934f4
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ITGA8 CPED1 EMILIN1 ABCA9 MRC2 LSAMP	3.07e-05	197	135	6	0dd71e399f253787fa546a7e90c5373180b89ffd
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ARHGAP15 CPED1 EMILIN1 ABCA9 MRC2	3.07e-05	197	135	6	ae0435f4b4a9cdedb1c201fc56921048390097bf
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ARHGAP15 CPED1 EMILIN1 ABCA9 MRC2	3.07e-05	197	135	6	37f6b6f2809b952382eaebb642b0aad6371f4251
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 ITGA8 CPED1 ABCA9 SLC2A3 MRC2	3.16e-05	198	135	6	79576525a10ed3e3a9d1608077cd16ecda23376f
ToppCell	COVID-19-kidney-Fibroblast-2\|kidney / Disease (COVID-19 only), tissue and cell type	TRERF1 CPED1 EMILIN1 ABCA9 SLC2A3 MRC2	3.16e-05	198	135	6	ca26ca460856b1faaa3e83766da6abdf63af2b51
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Macrophage_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCC3 GBP7 WDFY4 ALPK3 MMP9 SLC25A19	3.25e-05	199	135	6	98c0d57c247d39bc771d81f4387f8dd01222628e
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCC3 GBP7 WDFY4 ALPK3 MMP9 SLC25A19	3.25e-05	199	135	6	b818d46a39c8782188d82dc8931b8eec9d549dd1
ToppCell	COVID-19-kidney-Fibroblast-1\|kidney / Disease (COVID-19 only), tissue and cell type	TRERF1 CPED1 EMILIN1 ABCA9 SLC2A3 MRC2	3.25e-05	199	135	6	9503646ff1ad248181146ce767e9d12e882ec3bd
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ITGA8 CPED1 ABCA9 MRC2 NAV1 LSAMP	3.34e-05	200	135	6	b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCell	droplet-Lung-nan-3m-Myeloid-intermediate_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DDIT4 ERBB3 RB1 PKD1L2 UNC93B1	7.52e-05	143	135	5	4d11d53330a9197275a8851e1bbf55a113715a09
ToppCell	droplet-Lung-nan-3m-Myeloid-Intermediate_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DDIT4 ERBB3 RB1 PKD1L2 UNC93B1	7.52e-05	143	135	5	8b9f4d87d5faac7752c83e1992491fc5550600f8
ToppCell	Entopeduncular-Macroglia-OLIGODENDROCYTE-O1-Trf\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	CRYBG2 PIWIL4 DNAH14 FAT2	8.41e-05	76	135	4	efbbbf91bca35720d8ecddb076f2c9f4de25e44d
ToppCell	Entopeduncular-Macroglia-OLIGODENDROCYTE-O1\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	CRYBG2 PIWIL4 DNAH14 FAT2	8.41e-05	76	135	4	254d18bece2676faa4bbeb8d48b1d327ab3c2215
ToppCell	droplet-Kidney-nan-24m-Lymphocytic-CD45____macrophage\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA8 SLC2A3 TGM3 FBXL18 MMP9	9.43e-05	150	135	5	34774b015adecc2be56a471fda8994e89a6ad93e
ToppCell	P15-Epithelial-epithelial_progenitor_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ERBB3 KIF21A SLC34A2 COL5A3 CELSR1	1.00e-04	152	135	5	00d5503d462cfa009fb4cac79ecee11725a18b9a
ToppCell	Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1\|Thalamus / BrainAtlas - Mouse McCarroll V32	SLC43A1 CPED1 EMILIN1 ABCA9 MRC2	1.03e-04	153	135	5	e9c6fb5c41adb6595c66c3a917fe455348279e54
ToppCell	Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1\|Thalamus / BrainAtlas - Mouse McCarroll V32	SLC43A1 CPED1 EMILIN1 ABCA9 MRC2	1.03e-04	153	135	5	b8b5ff7d2feea3e3a352fb5530e49f639fe1ff88
ToppCell	PBMC-Control-cDC_8\|Control / Compartment, Disease Groups and Clusters	SLC43A1 TEX14 CEMIP2 ARHGEF37 MMP9	1.03e-04	153	135	5	db1a6914f2033fb0748e0523cffe5d6dc4e901be
ToppCell	Thalamus-Endothelial-ENDOTHELIAL_TIP\|Thalamus / BrainAtlas - Mouse McCarroll V32	SLC43A1 CPED1 EMILIN1 ABCA9 MRC2	1.03e-04	153	135	5	2513edfae62a44e51d3556675a096723194c966c
ToppCell	facs-MAT-Fat-24m-Myeloid-macrophage\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRERF1 SLC13A3 PKD1L2 WDFY4 UNC93B1	1.10e-04	155	135	5	d0c1608f8f6b6f4174e51d610501c707cba5e015
ToppCell	PBMC-Mild-cDC_6\|Mild / Compartment, Disease Groups and Clusters	RAF1 ANK1 ERN1 MOSPD1 MMP9	1.13e-04	156	135	5	3db686849844120b3e376599929d11ad06f0d577
ToppCell	droplet-Lung-3m-Hematologic-myeloid-interstitial_macrophage\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABCC3 SLC13A3 ABCA9 MMP9 GOT1	1.20e-04	158	135	5	9a6d9b541446a6aa9f8ed040b330dbb5c6447076
ToppCell	droplet-Lung-3m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABCC3 SLC13A3 ABCA9 MMP9 GOT1	1.20e-04	158	135	5	2438713d2a7e32c647ab3384237ed614f4ec8fec
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 COL5A3 CPED1 ABCA9 LILRA4	1.24e-04	159	135	5	e812cbde59188924c6277c3feadf1a9592fa62a4
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 COL5A3 CPED1 ABCA9 LILRA4	1.24e-04	159	135	5	2607b562903228274fbd96168ba826782fab0b53
ToppCell	390C-Myeloid-Macrophage-SPP1+_Macrophage_3\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	TRERF1 ERN1 MRC2 MASTL NOMO3	1.24e-04	159	135	5	af137688e06a97ff97bb7def54f0dd164d155b11
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1\|Hippocampus / BrainAtlas - Mouse McCarroll V32	SLC13A3 CPED1 EMILIN1 ABCA9 MRC2	1.24e-04	159	135	5	92049a8d8fc9997d8d0d76500c72596a9b2394e0
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_2\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CRYBG2 PIWIL4 SLC2A3 SV2A MMP9	1.28e-04	160	135	5	bb1bb3673059768c0ea0160d29fff127f3a4ecb4
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_2\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CRYBG2 PIWIL4 SLC2A3 SV2A MMP9	1.28e-04	160	135	5	76f49b8b4450fa8acd36326bfa36a5d1f4bd95fb
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 CPED1 EMILIN1 ABCA9 SLC2A3	1.35e-04	162	135	5	5f009b231f21861afee9cc0c569082e1135f929c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 CPED1 EMILIN1 ABCA9 SLC2A3	1.35e-04	162	135	5	b936f8040dcd4db621ccded19237af8df7d0ed6e
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_4\|356C / Donor, Lineage, Cell class and subclass (all cells)	ABCC3 WDFY4 PIP5KL1 ALPK3 LSAMP	1.35e-04	162	135	5	7d43d59531cbefe3ac94953b7faf7156b2a31441
ToppCell	droplet-Marrow-BM-30m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK1 SLC43A1 TMEM174 SLC16A1 MMP9	1.43e-04	164	135	5	f3772227f5aa75a3672d945f8d5bf3fa0b4e456b
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 FOXN2 ITGA8 CPED1 MRC2	1.43e-04	164	135	5	b6df1e67a5ce5f2d86f4e1420f4ee931f760bf4d
ToppCell	Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	SLC43A1 CPED1 EMILIN1 ABCA9 MRC2	1.47e-04	165	135	5	570483b43ccb5831feec9337b4664814431d40b1
Drug	Mefexamide hydrochloride [3413-64-7]; Down 200; 12.6uM; HL60; HG-U133A	HBS1L RB1 MARCHF7 SLC2A3 CREBZF LMBR1L CFAP74 DNAJC3 SMURF2 VPS13B	2.28e-07	198	131	10	1438_DN
Disease	ductal carcinoma in situ (is_marker_for)	FLT1 ERBB3 RB1 MMP9	2.11e-05	39	123	4	DOID:0060074 (is_marker_for)
Disease	Gastric Adenocarcinoma	ERBB3 ERN1 TEX14 TRRAP	3.75e-05	45	123	4	C0278701
Disease	Malignant neoplasm of breast	TRERF1 RAF1 FLT1 ERBB3 CYP2D6 ANK1 RB1 POU2F1 MOSPD1 NOP9 NUP133 LRBA HERC2 MMP9 VPS13B	4.22e-05	1074	123	15	C0006142
Disease	Ovarian Serous Adenocarcinoma	RAF1 ERN1 TRRAP	1.18e-04	23	123	3	C1335177
Disease	mood instability measurement	ARHGAP15 ADGRG6 NCOA5 LSAMP CSMD1	2.04e-04	128	123	5	EFO_0008475
Disease	childhood trauma measurement, alcohol consumption measurement	DDIT4 PCDHGA4 MARCHF7 NOMO2	2.25e-04	71	123	4	EFO_0007878, EFO_0007979
Disease	Child Development Disorders, Specific	WDFY4 LRP2 KCNT1	2.39e-04	29	123	3	C0085997
Disease	Child Development Deviations	WDFY4 LRP2 KCNT1	2.39e-04	29	123	3	C0085996
Disease	Developmental Disabilities	WDFY4 LRP2 KCNT1	2.64e-04	30	123	3	C0008073
Disease	birth weight	FLT1 ANK1 RB1 MARCHF7 CABLES1 ADGRG6 UMODL1 USH2A	2.78e-04	399	123	8	EFO_0004344
Disease	Large cell carcinoma of lung	TRRAP TTBK1 ALPK3	3.21e-04	32	123	3	C0345958
Disease	Schizophrenia	ERBB3 CYP2D6 ADNP2 ITGA8 TRRAP SLC18A1 SV2A LRP2 NAV1 LSAMP CSMD1 MMP9	3.30e-04	883	123	12	C0036341
Disease	Breast Carcinoma	TRERF1 RAF1 FLT1 ERBB3 CYP2D6 RB1 NOP9 HERC2 MMP9	4.36e-04	538	123	9	C0678222
Disease	helping behavior measurement	SLC52A3 USH2A	4.75e-04	8	123	2	EFO_0008538
Disease	parasitemia measurement	HUNK LSAMP CSMD1	4.95e-04	37	123	3	EFO_0005528
Disease	FEV/FEC ratio	FLT1 ERBB3 ARHGAP15 ITGA8 DGKD MCM7 DENND3 CEMIP2 ADGRG6 TG MRC2 NAV1 CSMD1 SMURF2	6.13e-04	1228	123	14	EFO_0004713
Disease	adult onset asthma, body mass index	ERBB3 POU2F1	7.59e-04	10	123	2	EFO_0004340, EFO_1002011
Disease	Unipolar Depression	DDIT4 ERBB3 CYP2D6 CXCL10 TG LSAMP	7.79e-04	259	123	6	C0041696
Disease	pigmentation disease (is_implicated_in)	TPCN2 HERC2	9.25e-04	11	123	2	DOID:10123 (is_implicated_in)
Disease	response to angiotensin-converting enzyme inhibitor, Cough	PKD1L2 CSMD1 VPS13B	9.41e-04	46	123	3	EFO_0005325, HP_0012735
Disease	response to radiation, hearing loss, response to antineoplastic agent	HUNK ADCY1 GOT1	9.41e-04	46	123	3	EFO_0004238, GO_0009314, GO_0097327
Disease	hepatocellular carcinoma (biomarker_via_orthology)	ABCC3 RB1 MCM7 GMPS	1.10e-03	108	123	4	DOID:684 (biomarker_via_orthology)
Disease	autoimmune thyroiditis (is_implicated_in)	TG LRP2	1.11e-03	12	123	2	DOID:7188 (is_implicated_in)
Disease	outer ear morphology trait	ADGRG6 LRBA	1.11e-03	12	123	2	EFO_0007664
Disease	C-C motif chemokine 28 measurement	HBS1L SLC2A3	1.11e-03	12	123	2	EFO_0020199
Disease	lymphangioleiomyomatosis (is_marker_for)	SLC16A1 MMP9	1.11e-03	12	123	2	DOID:3319 (is_marker_for)
Disease	cognitive inhibition measurement	ADGRG6 TGM3 USH2A	1.20e-03	50	123	3	EFO_0007969
Disease	bronchiolitis obliterans (is_marker_for)	CXCL10 MMP9	1.30e-03	13	123	2	DOID:2799 (is_marker_for)
Disease	Small cell carcinoma of lung	RB1 KIF21A ADCY1	1.50e-03	54	123	3	C0149925
Disease	membranous glomerulonephritis (biomarker_via_orthology)	LRP2 MMP9	1.52e-03	14	123	2	DOID:10976 (biomarker_via_orthology)
Disease	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K	FKRP POMGNT2	1.52e-03	14	123	2	C1836373
Disease	Kawasaki disease (is_marker_for)	FLT1 MMP9	1.52e-03	14	123	2	DOID:13378 (is_marker_for)
Disease	alpha-Dystroglycanopathies	FKRP POMGNT2	1.52e-03	14	123	2	C2936406
Disease	thoracic aortic aneurysm (is_marker_for)	CXCL10 MMP9	1.52e-03	14	123	2	DOID:14004 (is_marker_for)
Disease	Fukuyama Type Congenital Muscular Dystrophy	FKRP POMGNT2	1.52e-03	14	123	2	C0410174
Disease	autosomal dominant polycystic kidney disease (is_marker_for)	ITGA8 MMP9	1.52e-03	14	123	2	DOID:898 (is_marker_for)
Disease	Muscle eye brain disease	FKRP POMGNT2	1.52e-03	14	123	2	C0457133
Disease	pulmonary emphysema (is_marker_for)	CXCL10 MMP9	1.52e-03	14	123	2	DOID:9675 (is_marker_for)
Disease	Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies) Type A, 1	FKRP POMGNT2	1.52e-03	14	123	2	C4284790
Disease	Drug-Induced Liver Disease	FLT1 ERN1 CXCL10 BDH1 UNC93B1 MMP9 GOT1	1.56e-03	404	123	7	C0860207
Disease	Drug-Induced Acute Liver Injury	FLT1 ERN1 CXCL10 BDH1 UNC93B1 MMP9 GOT1	1.56e-03	404	123	7	C3658290
Disease	Hepatitis, Toxic	FLT1 ERN1 CXCL10 BDH1 UNC93B1 MMP9 GOT1	1.56e-03	404	123	7	C0019193
Disease	Chemically-Induced Liver Toxicity	FLT1 ERN1 CXCL10 BDH1 UNC93B1 MMP9 GOT1	1.56e-03	404	123	7	C4279912
Disease	Chemical and Drug Induced Liver Injury	FLT1 ERN1 CXCL10 BDH1 UNC93B1 MMP9 GOT1	1.56e-03	404	123	7	C4277682
Disease	Hepatitis, Drug-Induced	FLT1 ERN1 CXCL10 BDH1 UNC93B1 MMP9 GOT1	1.56e-03	404	123	7	C1262760
Disease	Mammary Carcinoma, Human	TRERF1 RAF1 FLT1 ERBB3 CYP2D6 RB1 NOP9 MMP9	1.64e-03	525	123	8	C4704874
Disease	Mammary Neoplasms, Human	TRERF1 RAF1 FLT1 ERBB3 CYP2D6 RB1 NOP9 MMP9	1.64e-03	525	123	8	C1257931
Disease	Mammary Neoplasms	TRERF1 RAF1 FLT1 ERBB3 CYP2D6 RB1 NOP9 MMP9	1.68e-03	527	123	8	C1458155
Disease	Walker-Warburg congenital muscular dystrophy	FKRP POMGNT2	1.75e-03	15	123	2	C0265221
Disease	Neoplasm of uncertain or unknown behavior of bladder	ERBB3 RB1	1.75e-03	15	123	2	C0496930
Disease	Benign neoplasm of bladder	ERBB3 RB1	1.75e-03	15	123	2	C0154017
Disease	body weights and measures, body height	CABLES1 SV2A	1.75e-03	15	123	2	EFO_0004324, EFO_0004339
Disease	Carcinoma in situ of bladder	ERBB3 RB1	1.75e-03	15	123	2	C0154091
Disease	Malignant neoplasm of skin	FLT1 ERBB3 MMP9	1.94e-03	59	123	3	C0007114
Disease	Skin Neoplasms	FLT1 ERBB3 MMP9	1.94e-03	59	123	3	C0037286
Disease	amygdala volume change measurement	PKD1L1 CSMD1	1.99e-03	16	123	2	EFO_0021490
Disease	Brain Ischemia	RB1 CXCL10 MMP9	2.03e-03	60	123	3	C0007786
Disease	Cerebral Ischemia	RB1 CXCL10 MMP9	2.03e-03	60	123	3	C0917798
Disease	eye colour measurement	CELSR1 SV2B LRP2 HERC2 USH2A	2.24e-03	218	123	5	EFO_0009764
Disease	metabolite measurement	ABCC3 CYP2D6 SLC13A3 PKD1L2 WDFY4 NCOA5 CSMD1 MMP9	2.45e-03	560	123	8	EFO_0004725
Disease	Carcinoma of bladder	ERBB3 RB1	2.52e-03	18	123	2	C0699885
Disease	squamous cell carcinoma	TPCN2 TGM3 HERC2	2.79e-03	67	123	3	EFO_0000707
Disease	Bladder Neoplasm	ERBB3 RB1 POLB MMP9	2.85e-03	140	123	4	C0005695
Disease	Malignant neoplasm of urinary bladder	ERBB3 RB1 POLB MMP9	2.92e-03	141	123	4	C0005684
Disease	cataract	PKD1L1 GMPS PIP5KL1 HERC2	2.92e-03	141	123	4	MONDO_0005129
Disease	kidney disease (biomarker_via_orthology)	ABCC3 MMP9	3.44e-03	21	123	2	DOID:557 (biomarker_via_orthology)
Disease	Major Depressive Disorder	DDIT4 ERBB3 CYP2D6 CXCL10 LSAMP	3.57e-03	243	123	5	C1269683
Disease	triacylglycerol 48:3 measurement	CACNA2D4 CSMD1	3.77e-03	22	123	2	EFO_0010406
Disease	Colonic Neoplasms	CXCL10 POLB SLC16A1 MMP9	3.82e-03	152	123	4	C0009375
Disease	CCL11 measurement	POMGNT2 LSAMP	4.12e-03	23	123	2	EFO_0005188

Protein segments in the cluster

Peptide	Gene	Start	Entry
GRLTLSTFTLEQPLG	UPK3BL1	56	B0FP48
GNASTTVSRLLLGLP	UMODL1	221	Q5DID0
VSIPFLQTALLRSSG	CEP170	451	Q5SW79
TLGSALSLPVGTLNR	ERBB3	1026	P21860
GFTIFLTALSRPGTS	CYB561D1	36	Q8N8Q1
SFVGLSQNLLLRSPG	COX18	286	Q8N8Q8
RLSGFQLPSSIVSTG	CSMD1	101	Q96PZ7
SSRPLGTFTKNELLG	CSMD1	1166	Q96PZ7
LGSLGQFQLLFPSTT	CPED1	461	A4D0V7
LLLGSTSFIPIGRRT	BDH1	31	Q02338
AGSSGLSFLLVIPLQ	ARHGEF37	156	A1IGU5
LLNILSGLSVPTSGS	ABCA9	526	Q8IUA7
LLPGTNAISNFSIGL	ADGRG6	686	Q86SQ4
LASRIIALGPTGAQF	ANK1	971	P16157
RTPGQVLSLISSLGF	MASTL	206	Q96GX5
LLVFGPSSETSLVGR	ALPK3	1651	Q96L96
ATSGGPTSFRLQILN	CELSR1	1731	Q9NYQ6
LQVTSRFQLPRGGLT	DENND3	1021	A2RUS2
SVTSRLGSVFPFLLV	DNAJC3	6	Q13217
TFLTSGSILRQLIPT	ADNP2	591	Q6IQ32
TPRSRILVSIGESFG	RB1	826	P06400
RQLLLFPNSTIGDSG	RAF1	191	P04049
PGVLLSLSGGLFRSN	NOMO3	891	P69849
FIPTSGLSGENLITR	HBS1L	441	Q9Y450
ALFAVIGRSSLNPGL	ABCC3	1211	O15438
RIVGLSLFPNLTSLT	LRRC9	46	Q6ZRR7
GRTQLFALNPRSGTL	PCDHGA4	101	Q9Y5G9
LVGPQRFSSAVGLVT	SLC16A1	381	P53985
STLVLFPGDLRTNLT	MMP9	26	P14780
GRKVSSLFGILSPSS	NUP133	256	Q8WUM0
PIIFSRNSGLVSITS	NUP133	461	Q8WUM0
FSTPGLVLRSLGALT	NOP9	496	Q86U38
PGVLLSLSGGLFRSN	NOMO2	891	Q5JPE7
TSLLFFGLSLGPRTR	LILRA4	6	P59901
PGSSLIFRTARSVQG	PIP5KL1	296	Q5T9C9
GIAIRTGSPLSLNLA	HERC2	4541	O95714
SIILSGTVLPSAQRF	LGALS9C	241	Q6DKI2
SIILSGTVLPSAQRF	LGALS9B	241	Q3B8N2
TITRLLLGLDTTPGS	KCNT1	971	Q5JUK3
TIGSFVLSATTLPLG	SLC43A1	81	O75387
VTGSISVLNPAFLGL	FAT2	1921	Q9NYQ8
NSLGFLPTTFILVGI	OR51J1	6	Q9H342
GRTVTISPFSGRLDI	PNPLA4	176	P41247
ISRQPLGATSGASLK	NCOA5	386	Q9HCD5
LILITSLSGSQGIFP	HHLA2	11	Q9UM44
PGVLLSLSGGLFRSN	NOMO1	891	Q15155
NRAVSSGPSLLTVFL	MOSPD1	151	Q9UJG1
GTSFGLPQTRRISLA	LRBA	2186	P50851
NIFLTGRLSSAVPAL	LRP3	26	O75074
SLLLGARTSNISKPG	MRC2	131	Q9UBG0
GQSAFSQLRLTPGLR	MIGA2	31	Q7L4E1
LLTESISRGTFFVPG	GBP7	416	Q8N8V2
TLGGNFRVPIVNSSL	LRP2	2536	P98164
GAQLVTTLFLPRGAT	POMGNT2	346	Q8NAT1
SGFNGFTPLVTLLLR	HUWE1	1811	Q7Z6Z7
VSSLLFRDPQILTGT	ITGA8	366	P53708
VSVTGIFLPILRTGF	MCM7	271	P33993
LATIQALASGGSLPI	POU2F1	636	P14859
APGRDLTVGITTFLS	PKD1L2	1266	Q7Z442
ISFVLLGLTTSPGQQ	OR1K1	11	Q8NGR3
SLVVLSSGGQRTALP	ADCY1	706	Q08828
TPTFLTTGVLSTLRQ	GMPS	576	P49915
SRGRLNSFTQGILPI	CABLES1	236	Q8TDN4
TLLLPGLGIFGSTST	ERN1	11	O75460
LPGFSQSLTLSTGFR	DDIT4	201	Q9NX09
ISDTPFSLGVVLSRG	CACNA2D4	641	Q7Z3S7
GFRIPKGTTLITNLS	CYP2D6	386	P10635
LSHGPGIRLFNLTST	FUT11	156	Q495W5
LIFLTLSGIQGVPLS	CXCL10	11	P02778
TSRLGGSLLFGSLVP	CRYBG2	901	Q8N1P7
VTGRGSFRPIQSSLT	CRAMP1	916	Q96RY5
PTQLSTGAISFLRSL	HUNK	286	P57058
QQLVSTFRLPSGVGA	ABCA2	1526	Q9BZC7
YLLPSGRINVSGLTT	GOT1	381	P17174
TLLARTLNSSGLPFG	CEMIP2	241	Q9UHN6
SRILATTGLPTNFLT	DNAH14	3466	Q0VDD8
RNTGISGILPGSLFR	MARCHF7	471	Q9H992
SLPGGSVISRLLINA	DGKD	731	Q16760
TNLLTNFSLGSEGLP	FOXN2	66	P32314
SPTALRGAFGTLNQL	SLC2A3	146	P11169
SALTLVPITGRSFSL	CCDC177	291	Q9NQR7
SQPSPGTLGVFSLIL	EMILIN1	961	Q9Y6C2
RPVGTSLFLQTALRG	FKRP	216	Q9H9S5
GRVSVFQTQLPSLGA	SEC24B	806	O95487
GFSGLNLNIPILSSL	RPRD2	681	Q5VT52
GTATLTGTAPNLILL	SLC13A3	246	Q8WWT9
SINFLTRVSGIGPSA	POLB	96	P06746
VSPTLGSFRVGLLCT	PKD1L1	1986	Q8TDX9
LLRAGGTQVLVLSFS	CFAP74	1296	Q9C0B2
PRFISIAGLTVLGTQ	COL5A3	176	P25940
LDLIRPGSFQGLTSL	LRRC4B	241	Q9NT99
PGSLVGLNLSSLAIT	LINGO4	246	Q6UY18
TSGFILLGLSSNPQL	OR1L6	46	Q8NGR2
SLLSTKQGGLTPSRL	NAV1	701	Q8NEY1
NTSNLTGILTGLLPF	USH2A	2011	O75445
GRLTLSTFTLEQPLG	UPK3BL2	56	E5RIL1
LPALVALAQGSGLTT	SLC52A3	151	Q9NQ40
KRLSSFIGAGSPSLV	TEX14	1286	Q8IWB6
VSFLGSLSVLPGNII	SV2B	541	Q7L1I2
VLSSALPVFSRTLGL	LMBR1L	401	Q6UX01
LGVTNASLVLFRPGS	LSAMP	296	Q13449
TLALGGPFLLTSVSL	NTN5	66	Q8WTR8
TTLITAGRLVSAQFP	MOV10	621	Q9HCE1
QRRFSILGGPILGTS	TAF1C	171	Q15572
LTLAQLPSVLTGSGL	FBXL18	536	Q96ME1
LHFGSQISLTGRIVP	PIWIL4	436	Q7Z3Z4
STQSLGIVFGPTLLR	ARHGAP15	426	Q53QZ3
SFLGTLAVLPGNIVS	SV2A	601	Q7L0J3
FAGTLNTALRSLGIP	TGM3	276	Q08188
LLSLIFSSPGNGTRR	B3GALT9	86	A8MXE2
FTSALTPLIGIGVIT	SLC34A2	436	O95436
LLQFVTGSSRVPLQG	SMURF2	671	Q9HAU4
QPRGTFTLSTTLRLG	TTBK1	121	Q5TCY1
GILSGFNKTVLRTLP	UNC93B1	266	Q9H1C4
IFTSGTTGLPKAARI	SLC27A3	286	Q5K4L6
GLPSKIGSISRQSSL	KIF21A	1216	Q7Z4S6
GGLPSNISSVSSLLL	WASH2P	161	Q6VEQ5
GGLPSNISSVSSLLL	WASHC1	161	A8K0Z3
VLRQFLGLGIPSSLS	WDFY4	921	Q6ZS81
GVGLRLTTSLFRDSP	CREBZF	286	Q9NS37
LSIRGTLFVPQNSGL	STAB2	2351	Q8WWQ8
RGIGLFPSNFVTTNL	STAM2	246	O75886
GTPGTLITIQGRIFT	PKHD1L1	156	Q86WI1
SLTAIKTRAPQLGGS	TIMM17A	51	Q99595
TQLLGPVLLSVGVTF	TMEM174	71	Q8WUU8
PSSVRSTLLELFGQI	WDR37	51	Q9Y2I8
PGIILGSSFLLSIND	VPS13B	2176	Q7Z7G8
LGPLVGFLGTESTRQ	STRCP1	1326	A6NGW2
LLTLESRGSSGPTQI	STRN4	626	Q9NRL3
GIILGPGSSTLFIER	FLT1	706	P17948
GGFIPGSLTARSLQI	TG	1056	P01266
AGSVSGLVTRALISP	SLC25A19	21	Q9HC21
FITLLLPGGAQTAVR	TRRAP	1611	Q9Y4A5
FRGVIVALPGNSSLA	TPCN2	601	Q8NHX9
PGISTALTRLITGDF	TTI1	211	O43156
TLLFVARTLQGIGSS	SLC18A1	191	P54219
PVRQGSGLFSNVLIS	TRERF1	716	Q96PN7